-The Hindu Ministry concedes Q1 growth to be hit, bats for expanding vaccination pace. The second COVID-19 wave which is spreading fast beyond the worst-affected districts in the country, could dent economic activity till June this year, and expanding vaccination pace in the country is the “need of the hour”, the Finance Ministry said on Friday. The Ministry also indicated it is not in favour of a national lockdown to curb the pandemic,...

-The Hindu ‘Economy taking a severe hit from 2nd wave; Growth hopes fading' The second wave of the COVID-19 pandemic has engulfed rural India, spreading far beyond the worst hit cities and districts, with nearly half the country’s new cases being reported from rural districts, an SBI research report said on Friday. Red-flagging the slowing vaccination pace from an average 28 lakhs per day in April to just 17 lakhs per day, the...

-The Hindu Savvy urban residents book slots in rural PHCs while villagers sans smart phones are unable to register The government-mandated online registration process for COVID-19 vaccination has starkly exposed the digital divide in Telangana, with the Internet savvy urban population cornering access while the poorer, less aware rural people are left out as the second phase is rolled out. Unable to find online slot in the Twin Cities, several urban residents are...

-Hindustan Times A rapid and universal vaccination programme is essential to control a surge of this magnitude and time is of the essence — for the virus is not standing still The second wave of Covid-19 is overwhelming India. The official death toll is already inching towards 250,000, but this is almost surely a vast underestimate, as the virus sweeps through rural India and kills many whose deaths will never be captured...

-The Hindu Business Line It’s only an open-ended deal with co-developer Bharat Biotech, says top source The Indian Council of Medical Research (ICMR) is willing to share the know-how to produce the indigenously-developed Covid-19 vaccine, Covaxin, with any company as the contract with co-developer Bharat Biotech is not close-ended. Currently, Bharat Biotech has the sole licence to manufacture Covaxin, which it developed in collaboration with scientists from ICMR’s Pune-based National Institute of Virology...